Basal-like breast cancer: A review

被引:4
|
作者
Treilleux, Isabelle [1 ]
Morellon-Mialhe, Blandine [1 ]
机构
[1] Ctr Leon Berard, Serv Anat Pathol, F-69373 Lyon 08, France
关键词
Breast cancer; Basal phenotype; Basal cytokeratins; Myoepithelial markers; Immunohistochemistry; Prognosis; IN-SITU HYBRIDIZATION; DUCTAL CARCINOMA; EPITHELIAL PHENOTYPE; EXPRESSION; SUBTYPE; AMPLIFICATION; MUTATIONS; RECEPTOR; MARKERS; EGFR;
D O I
10.1016/j.annpat.2009.04.001
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Breast cancers of basal phenotype have been identified by molecular profiting and are associated with a poor prognosis. This review describes the morphological characteristics of these tumors and focuses on their profiting using immunohistochemistry: absence of detectable hormone receptors and HER2, expression of basal cytokeratins (CK5/6, CK14), myoepithelial markers (p63, smooth muscle actin) and HER1. This phenotype may be encountered in all histological types of breast cancer and is further divided into three subtypes according to prognosis and protein profiting. Pure basal and basal/myoepithelial subtypes have a poor prognosis in contrast to the myoepithelial subtype. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:180 / 186
页数:7
相关论文
共 50 条
  • [21] Vascular proliferation is increased in basal-like breast cancer
    Nalwoga, Hawa
    Arnes, Jarle B.
    Stefansson, Ingunn M.
    Wabinga, Henry
    Foulkes, William D.
    Akslen, Lars A.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (03) : 1063 - 1071
  • [22] The Proliferative and Apoptotic Landscape of Basal-like Breast Cancer
    Alexandrou, Sarah
    George, Sandra Marie
    Ormandy, Christopher John
    Lim, Elgene
    Oakes, Samantha Richelle
    Caldon, C. Elizabeth
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03)
  • [23] Frequency of the basal-like phenotype in African breast cancer
    Nalwoga, Hawa
    Arnes, Jarle B.
    Wabinga, Henry
    Akslen, Lars A.
    APMIS, 2007, 115 (12) : 1391 - 1399
  • [24] BRCAness and PD-L1 expression of basal-like and not basal-like triple negative breast cancer
    Mori, H.
    Kubo, M.
    Yamada, M.
    Kai, M.
    Osako, T.
    Nishimura, R.
    Arima, N.
    Okido, M.
    Kuroki, S.
    Oda, Y.
    Nakamura, M.
    CANCER RESEARCH, 2016, 76
  • [25] Basal-like Breast Cancer: Comparison of Imaging Characteristics
    Choi, Bo Bae
    Jang, Hyeon Ji
    Choi, Song, I
    CURRENT MEDICAL IMAGING, 2020, 16 (03) : 241 - 248
  • [26] A Survey of 45 Biomarkers for Basal-Like Breast Cancer
    Choo, J. R.
    Gao, D.
    Leung, S.
    Chow, C.
    Lau, S. Y. H.
    Cheng, J.
    Nielsen, T. O.
    MODERN PATHOLOGY, 2011, 24 : 32A - 33A
  • [27] Basal-like subtype of breast cancer: a review of its unique characteristics and their clinical significance
    Kobayashi, Shunzo
    BREAST CANCER, 2008, 15 (02) : 153 - 158
  • [28] Basal-like subtype of breast cancer: a review of its unique characteristics and their clinical significance
    Shunzo Kobayashi
    Breast Cancer, 2008, 15 : 153 - 158
  • [29] YAP and cancer stem cells in basal-like breast cancer.
    Quinn, Hazel M.
    Vogel, Regina
    Birchmeier, Walter
    MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 29 - 30
  • [30] Inhibition of Notch reverses immunosuppression in basal-like breast cancer
    Shen, Qiang
    Murakami, Kiichi
    Ohashi, Pamela
    Reedijk, Michael
    CANCER RESEARCH, 2023, 83 (07)